Clinical trial
PRO-TECT II: Propofol Cardioprotection for Type II Diabetics
NCT00734383 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PRO-TECT II: Propofol Cardioprotection for Type II Diabetics
- Lead sponsor
- University of British Columbia
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- April 30, 2005
- Completion date
- June 30, 2012
- Enrollment
- 137 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
myocardial injury